Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nikaido, H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264, 382–388 (1994).
Pechère, J.C. Macrolide resistance mechanisms in gram-positive cocci. Int. J. Antimicrob. Agents 18 Suppl. 1, S25–S28 (2001).
Wang, F., Zhu, D., Hu, F. & Zhang, Y. Surveillance of bacterial resistance among isolates in Shanghai in 1999. J. Infect. Chemother. 7, 117–120 (2001).
Wetzstein, H.G., Schmeer, N. & Karl, W. Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites. Appl. Environ. Microbiol. 63, 4272–4281 (1997).
Wang, M. et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47, 2242–2248 (2003).
Wang, M., Sahm, D.F., Jacoby, G.A. & Hooper, D.C. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48, 1295–1299 (2004).
Robicsek, A., Sahm, D.F., Strahilevitz, J., Jacoby, G.A. & Hooper, D.C. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob. Agents Chemother. 49, 3001–3003 (2005).
Tolmasky, M.E., Roberts, M., Woloj, M. & Crosa, J.H. Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 30, 315–320 (1986).
Domagala, J.M. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J. Antimicrob. Chemother. 33, 685–706 (1994).
Heisig, P. & Tschorny, R. Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro. Antimicrob. Agents Chemother. 38, 1284–1291 (1994).
Neuhauser, M.M. et al. Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use. J. Am. Med. Assoc. 289, 885–888 (2003).
Martinez-Freijo, P. et al. Class I integrons in gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J. Antimicrob. Chemother. 42, 689–696 (1998).
Boyd, D.A. et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48, 3758–3764 (2004).
Vetting, M.W., Magnet, S., Nieves, E., Roderick, S.L. & Blanchard, J.S. A bacterial acetyltransferase capable of regioselective N-acetylation of antibiotics and histones. Chem. Biol. 11, 565–573 (2004).
Bennett, A.D. & Shaw, W.V. Resistance to fusidic acid in Escherichia coli mediated by the type I variant of chloramphenicol acetyltransferase. Biochem. J. 215, 29–38 (1983).
Murray, I.A. et al. Steroid recognition by chloramphenicol acetyltransferase: engineering and structural analysis of a high affinity fusidic acid binding site. J. Mol. Biol. 254, 993–1005 (1995).
Davies, J.E. Aminoglycoside-aminocyclitol antibiotics and their modifying enzymes. in Antibiotics in Laboratory Medicine (ed. Lorian, V.), 790–809 (Williams & Wilkins, Baltimore, 1986).